(Q36484592)

14 August 2017

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies (English)

1 reference

14 August 2017

12

A Vincent-Salomon

1 reference

14 August 2017

M A Bollet

1

1 reference

14 August 2017

A Savignoni

2

1 reference

14 August 2017

J-Y Pierga

3

1 reference

14 August 2017

M Lae

4

1 reference

14 August 2017

V Fourchotte

5

1 reference

14 August 2017

Y M Kirova

6

1 reference

14 August 2017

R Dendale

7

1 reference

14 August 2017

F Campana

8

1 reference

14 August 2017

B Sigal-Zafrani

9

1 reference

14 August 2017

R Salmon

10

1 reference

14 August 2017

A Fourquet

11

1 reference

14 August 2017

language of work or name

English

0 references

publication date

5 February 2008

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

98

1 reference

14 August 2017

4

1 reference

14 August 2017

734-741

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604229

14 August 2017

0 references

cites work

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Primary systemic chemotherapy of invasive lobular carcinoma of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Challenges to interpretation of breast MRI.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

[Breast MRI in invasive lobular carcinoma: diagnosis and staging]

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

[Dynamic MR-mammography in invasive lobular breast cancer]

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2259192

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

21 September 2018

1 reference

12 December 2020

The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast

1 reference

12 December 2020

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

12 December 2020

Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation

1 reference

12 December 2020

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer

1 reference

12 December 2020

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1 reference

12 December 2020

Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas

1 reference

12 December 2020

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile

1 reference

12 December 2020

The role of MRI in invasive lobular carcinoma

1 reference

12 December 2020

MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy

1 reference

12 December 2020

[Conservative surgery after preoperative radiotherapy in the treatment of breast cancer. Indications and results]

1 reference

12 December 2020

External irradiation prior to conservative surgery for breast cancer treatment

1 reference

12 December 2020

Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy

1 reference

12 December 2020

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

12 December 2020

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution

1 reference

12 December 2020

Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology

1 reference

12 December 2020

Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604229

1 reference

14 August 2017

1 reference

14 August 2017

1 reference